Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan · Delayed Price · Currency is TWD 389.50
-1.50 (-0.38%)
Feb 11, 2026, 1:21 PM CST
Sunmax Biotechnology Market Cap
Sunmax Biotechnology has a market cap or net worth of 21.3 billion as of February 11, 2026. Its market cap has increased by 39.39% in one year.
Market Cap
21.30B
Enterprise Value
20.68B
Revenue
2.00B
Ranking
n/a
PE Ratio
29.73
Stock Price
389.50
Market Cap Chart
Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 21.30B, an increase of 1,332.00%. That is a compound annual growth rate of 18.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 21.30B | -1.26% |
| Dec 31, 2025 | 21.57B | 41.43% |
| Dec 30, 2024 | 15.25B | 37.25% |
| Dec 29, 2023 | 11.11B | 50.00% |
| Dec 30, 2022 | 7.41B | 64.65% |
| Dec 30, 2021 | 4.50B | 2.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 33.88B |
| Lumosa Therapeutics | 30.58B |
| Oneness Biotech | 27.89B |
| Polaris Group | 22.46B |
| EirGenix | 18.13B |
| AP Biosciences | 14.63B |
| TaiMed Biologics | 14.53B |
| Ever Supreme Bio Technology | 13.31B |